A composition for weight reduction and body fat reduction, its preparation method and application are disclosed, which relates to the technical field of health food. The composition includes the following components: 10-30 parts of concentrated milk protein, 10-30 parts of soybean isolated protein powder, 10-30 parts of concentrated whey protein powder, 5-15 parts of skim milk powder, 0.5-15 parts of collagen peptide, 0.1-3 parts of Agaricus bisporus extract, 0.1-3 parts of Flammulina velutipes extract, 0.1-5 parts of okra powder, 0.1-2 parts of Opuntia ficus-indica extract, 1-10 parts of medium chain triglyceride microcapsule powder, 0.1-5 parts of mango concentrated powder, 0.1-2 parts of ginger oil microcapsule powder, 0.1-2 parts of citrus powder, 0.1-5 parts of guarana extract and 0.5-2 parts of compound vitamin.

Various aspects of this patent document relate to liquid compositions comprising cannabidiol, which have either freezing points or glass-liquid transition temperatures less than the melting point of pure cannabidiol.

An orally ingestible contraceptive low dose gossypol composition for rodents such as mice, rats and members of the order Rodentia is provided. The contraceptive composition comprises 0.0005 to 0.0045 wt. % of gossypol and a carrier. The carrier includes a bulk feed component. The bait or soft bait may be encased in a casing such as a collagen casing. Also provided is a method for contraception of rodents comprising administering the low dose-gossypol composition by making the contraceptive available for feeding the target animal.

The present invention relates to a shelf-stable veterinary formulation for promoting eye health and/or comfort in a companion animal consisting of a palatable ductile chewable veterinary composition comprising an omega-3 fatty acid oil; at least one anti-inflammatory plant extract; and at least one carotenoid. The present invention also relates to methods of promoting eye health and/or comfort in a companion animal using such compositions.

Various aspects of this patent document relate to liquid compositions comprising cannabidiol, which have either freezing points or glass-liquid transition temperatures less than the melting point of pure cannabidiol.

Disclosed are equine supplement compositions for enhancing the health and well-being of horses. For instance, a composition may include a first portion containing one or more components selected from slippery elm, milk thistle, spirulina, marshmallow root, licorice root, alfalfa leaf, and ashwaganda; and a second portion containing one or more components selected from lysine, MSM, and goji berry. Additionally, a second composition may include an oil component selected from flax seed oil and coconut oil, combined with a honey component comprising manuka honey. Furthermore, a third composition may include a vitamin E component and a selenium component. The supplemental compositions provides a novel, cost-effective, simple, effective, efficient, and sustainable solution for supporting the overall health, performance, and longevity of horses by providing essential nutrients and beneficial compounds that target various aspects of equine health.

A composition for weight reduction and body fat reduction, its preparation method and application are disclosed, which relates to the technical field of health food. The composition includes the following components: 10-30 parts of concentrated milk protein, 10-30 parts of soybean isolated protein powder, 10-30 parts of concentrated whey protein powder, 5-15 parts of skim milk powder, 0.5-15 parts of collagen peptide, 0.1-3 parts of Agaricus bisporus extract, 0.1-3 parts of Flammulina velutipes extract, 0.1-5 parts of okra powder, 0.1-2 parts of Opuntia ficus-indica extract, 1-10 parts of medium chain triglyceride microcapsule powder, 0.1-5 parts of mango concentrated powder, 0.1-2 parts of ginger oil microcapsule powder, 0.1-2 parts of citrus powder, 0.1-5 parts of guarana extract and 0.5-2 parts of compound vitamin.

The invention relates to a flavonoid active fraction of an Abelmoschi corolla, a preparation method and an application thereof, and belongs to the field of traditional Chinese pharmaceutics. A high-purity Abelmoschi corolla flavonoid active fraction is prepared, which is found to have better therapeutic activity for kidney disease, and especially have a significant therapeutic effect for diabetic kidney disease and lupus nephritis, or contrast-induced kidney injury and eye diseases. Meanwhile, the Abelmoschi corolla flavonoid active fraction described in the invention also has good safety.

Gummy dosage forms and methods of making and using the same are provided. Such dosage forms can have multiple components including center and outer portions in which at least one portion comprises one or more therapeutic ingredients. The center portion can be a liquid or semi-solid and have a different texture than the outer portion. The outer portion can be a semi-solid or solid, at least partially cover the center portion, and include marshmallow root.

The present disclosure relates to compositions containing natural plant extracts that inhibit Hyaluronidase 1 and their use in effectively treating conditions such as dryness of skin and lips, skin damage due to UV radiation, chronic inflammatory conditions affecting the skin, the urinary bladder or prostate, osteoarthritis and joint pain, and also promoting wound healing.